These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6654158)

  • 41. Protection of the myocardium during ischemic arrest.
    Johnson WD
    Singapore Med J; 1973 Sep; 14(3):466. PubMed ID: 4777939
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effects of anoxia and ischemia on the ultrastructure and metabolism of the myocardium. Ultrastructure of the myocardium after ischemia and reperfusion].
    Schaper J
    Coeur Med Interne; 1979; 18(4):617-8. PubMed ID: 553760
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cardioplegic haemoglobin-perfusion for myocardial protection. Experiments on isolated rat-hearts (author's transl)].
    Ottermann U
    Anaesthesist; 1980 Apr; 29(4):190-9. PubMed ID: 7425249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart.
    Shlafer M; Kane PF; Kirsh MM
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):830-9. PubMed ID: 7087509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Temperature threshold and modulation of energy metabolism in the cardioplegic arrested rabbit heart.
    Ning XH; Xu CS; Song YC; Childs KF; Xiao Y; Bolling SF; Lupinetti FM; Portman MA
    Cryobiology; 1998 Feb; 36(1):2-11. PubMed ID: 9500928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of intermittent infusions of glucose-containing crystalloid cardioplegic solution on myocardial tissue lactic acid and recovery of contractility.
    Guilbeau EJ; Moore LK; Viole AJ; Mathis TR; Switzer AJ; Brandon TA; Martin M; Fisk RL
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):920-9. PubMed ID: 6727413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of the efficacy of human heart protection during cardioplegia].
    Krymskiĭ LD; Artiukhina TV; Blagoveshchenskaia RP
    Arkh Patol; 1983; 45(1):17-25. PubMed ID: 6847399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hyperpolarized cardiac arrest with ATP-sensitive potassium channel opener on myocardial protection during CPB].
    Yu T; Liu X; Yu Z; Yang S; Ye Y; Yang X; Gao Z
    Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):931-4. PubMed ID: 11832201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anti-ischemic protection of the myocardium during cardioplegia on the basis of fluorocarbon emulsions].
    Islamov BI
    Grudn Khir; 1986; (5):31-4. PubMed ID: 3781306
    [No Abstract]   [Full Text] [Related]  

  • 50. [Protection of oxyphenamone against cardiac arrest-reperfusion injury of isolated rat hearts].
    Fan LL; Li H; Fan MJ; Zhang RD
    Yao Xue Xue Bao; 2005 Aug; 40(8):705-10. PubMed ID: 16268504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of cold blood cardioplegia to protect against coronary microcirculatory injury due to ischemia and reperfusion.
    McDonagh PF; Laks H
    J Thorac Cardiovasc Surg; 1982 Oct; 84(4):609-18. PubMed ID: 7121048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits].
    Zhou RH; Long C; Liu J; Liu B
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The energy metabolism of the heart during ischemia and during post-ischemic regeneration with and without artificial cardiac arrest.
    Kubler W; Spieckermann PG; Grebe D; Bretschneider HJ
    Br J Surg; 1969 Aug; 56(8):630. PubMed ID: 5805319
    [No Abstract]   [Full Text] [Related]  

  • 54. Perfusion in cardioplegia: an experimental study.
    Addetia A; Callaghan JC
    Can J Surg; 1980 Mar; 23(2):146-50. PubMed ID: 7363175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of multiple-dose potassium cardioplegia on myocardial ischemia, return of ventricular function, and ultrastructural preservation.
    Lucas SK; Elmer EB; Flaherty JT; Prodromos CC; Bulkley BH; Gott BL; Gardner TJ
    J Thorac Cardiovasc Surg; 1980 Jul; 80(1):102-10. PubMed ID: 6770201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of sympathetic nerve system on the precipitation of cardiac ischemia--effects of hyperlipidemia on the changes of coronary circulation, cardiac function and myocardial metabolism produced by sympathetic nerve stimulation in dog hearts with moderate coronary-constriction].
    Yoshida S; Sato R; Nohara K; Kudo Y; Motoe M; Ishiyama N; Iimura O
    Kokyu To Junkan; 1983 Jan; 31(1):25-8. PubMed ID: 6857012
    [No Abstract]   [Full Text] [Related]  

  • 57. [Protection of the myocardium during hypothermal potassium cardioplegia].
    Levitskiĭ S; Faĭnberg G
    Vestn Akad Med Nauk SSSR; 1981; (10):3-9. PubMed ID: 7314880
    [No Abstract]   [Full Text] [Related]  

  • 58. [Myocardial protection during ischemic cardiac arrest. Hemodynamic study of the effects of allopurinol in a cardioplegic solution].
    Périer P; Fabiani JN; Bocher M; Massoud H; Carpentier A; Dubost C
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):713-8. PubMed ID: 6779765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Histochemical demonstration of phosphorylase activity in the myocardium of laboratory animals after the standstill of the heart due to ischemia].
    Ebner E; Schulze W
    Gegenbaurs Morphol Jahrb; 1967; 111(1):91-8. PubMed ID: 5599537
    [No Abstract]   [Full Text] [Related]  

  • 60. [Metabolism of the ischemic myocardium].
    Moret PR
    Ann Cardiol Angeiol (Paris); 1971; 20(6):691-7. PubMed ID: 5146723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.